Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) EBT: 2010-2024

Historic EBT for Kura Oncology (KURA) over the last 7 years, with Dec 2024 value amounting to -$172.0 million.

  • Kura Oncology's EBT fell 36.23% to -$74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$214.6 million, marking a year-over-year change of. This contributed to the annual value of -$172.0 million for FY2024, which is 12.67% down from last year.
  • As of FY2024, Kura Oncology's EBT stood at -$172.0 million, which was down 12.67% from -$152.6 million recorded in FY2023.
  • Over the past 5 years, Kura Oncology's EBT peaked at -$135.8 million during FY2022, and registered a low of -$172.0 million during FY2024.
  • Over the past 3 years, Kura Oncology's median EBT value was -$152.6 million (recorded in 2023), while the average stood at -$153.5 million.
  • Data for Kura Oncology's EBT shows a maximum YoY declined of 12.67% (in 2024) over the last 5 years.
  • Kura Oncology's EBT (Yearly) stood at -$135.8 million in 2022, then fell by 12.36% to -$152.6 million in 2023, then dropped by 12.67% to -$172.0 million in 2024.